Enlivex Therapeutics Ltd (ENLV)
1.62
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.64
+0.02
(+1.23%)
After-Hours: 20:00
Enlivex Therapeutics Price to Book Value: 1.013 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.013 |
| May 02, 2024 | 1.013 |
| May 01, 2024 | 1.007 |
| April 30, 2024 | 1.044 |
| April 29, 2024 | 1.038 |
| April 26, 2024 | 0.9004 |
| April 25, 2024 | 0.9067 |
| April 24, 2024 | 0.938 |
| April 23, 2024 | 0.8254 |
| April 22, 2024 | 0.7941 |
| April 19, 2024 | 0.8254 |
| April 18, 2024 | 0.8754 |
| April 17, 2024 | 0.9255 |
| April 16, 2024 | 0.9067 |
| April 15, 2024 | 0.8129 |
| April 12, 2024 | 0.988 |
| April 11, 2024 | 1.144 |
| April 10, 2024 | 2.489 |
| April 09, 2024 | 2.551 |
| April 08, 2024 | 2.564 |
| April 05, 2024 | 2.501 |
| April 04, 2024 | 2.351 |
| April 03, 2024 | 2.695 |
| April 02, 2024 | 2.526 |
| April 01, 2024 | 2.501 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.343 |
| March 27, 2024 | 2.386 |
| March 26, 2024 | 2.417 |
| March 25, 2024 | 2.541 |
| March 22, 2024 | 2.275 |
| March 21, 2024 | 2.219 |
| March 20, 2024 | 2.485 |
| March 19, 2024 | 2.516 |
| March 18, 2024 | 2.584 |
| March 15, 2024 | 2.541 |
| March 14, 2024 | 2.547 |
| March 13, 2024 | 2.658 |
| March 12, 2024 | 2.578 |
| March 11, 2024 | 2.287 |
| March 08, 2024 | 2.442 |
| March 07, 2024 | 2.090 |
| March 06, 2024 | 2.077 |
| March 05, 2024 | 2.003 |
| March 04, 2024 | 2.114 |
| March 01, 2024 | 1.984 |
| February 29, 2024 | 1.920 |
| February 28, 2024 | 1.805 |
| February 27, 2024 | 1.892 |
| February 26, 2024 | 1.855 |
| February 23, 2024 | 1.879 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6125
Minimum
Sep 22 2023
25.95
Maximum
Sep 23 2019
3.566
Average
1.875
Median
Jun 07 2021
Price to Book Value Benchmarks
| Compugen Ltd | 2.882 |
| Pluri Inc | 6.832 |
| BioLine Rx Ltd | 4.111 |
| Can Fite Biofarma Ltd | 1.671 |
| BiomX Inc | 6.881 |
Price to Book Value Related Metrics
| Price | 1.62 |
| Earnings Yield | -96.30% |
| Market Cap | 30.48M |